Reply to: “May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?” and “Has the time come for using MELD-Sarcopenia score?”

We would like to thank Lucidi et al.1 and De et al.2 for their interest in our work3 and for highlighting some challenging issues regarding the impact of low skeletal muscle mass in liver transplant candidates with cirrhosis.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research